Lindynette 30 (Ethinylestradiol, Gestodene)

Lindynette 30, a combined oral contraceptive, is used in the hormonal contraception pathway to prevent pregnancy and manage menstrual cycle disorders.

• Prevention of pregnancy: provides reliable contraceptive protection by suppressing ovulation.
• Regulation of menstrual cycle: helps achieve more predictable bleeding patterns and reduces cycle irregularities.
• Management of dysmenorrhea: may lessen menstrual pain through hormonal stabilization.

• Lindynette 30 combines ethinylestradiol, a synthetic estrogen, with gestodene, a progestogen, to suppress the hypothalamic‑pituitary‑ovarian axis, reducing the secretion of luteinizing hormone and follicle‑stimulating hormone. This inhibition prevents follicular development and ovulation, while the progestogen component thickens cervical mucus and alters endometrial growth, creating an environment unfavorable for fertilization and implantation.

Lindynette 30 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild to moderate stomach upset.
• Breast tenderness: temporary swelling or discomfort.
• Headache: occasional mild to moderate pain.
• Weight gain: slight increase in body weight.

Serious or Rare Side Effects

• Venous thromboembolism: blood clots in deep veins or lungs.
• Hypertension: significant increase in blood pressure.
• Severe allergic reaction: rash, swelling, or difficulty breathing.
• Liver dysfunction: abnormal liver enzyme levels or jaundice.

Before prescribing Lindynette 30, clinicians should consider several safety aspects.

• Cardiovascular risk assessment: evaluate history of thromboembolic events or smoking.
• Liver function monitoring: avoid use in active liver disease.
• Migraine evaluation: caution in patients with migraine with aura.
• Breast cancer screening: contraindicated in known or suspected hormone‑sensitive cancers.
• Smoking status: advise cessation, especially in women over 35.
• Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Lindynette 30 can interact with other medicines, altering its effectiveness or safety.

Major Interactions (Avoid)

• Strong CYP3A4 inducers (e.g., rifampicin, carbamazepine): may markedly reduce contraceptive efficacy.
• Anticoagulants (e.g., warfarin): may increase clotting risk.

Moderate Interactions (Monitor Closely)

• Antifungals (e.g., ketoconazole, itraconazole): can raise hormone levels, increasing side‑effect risk.
• Certain antibiotics (e.g., tetracycline, metronidazole): may slightly lower contraceptive effectiveness.
• Herbal supplements (e.g., St. John’s wort): may reduce plasma concentrations of the active hormones.